SNDX
Syndax Pharmaceuticals Inc
18.20$
+1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -387.2% | -2,881.7% | -2,247.2% | -4,517.5% | -3,336.3% | -4,697.4% | 20.9% | -105.6% | – | -1,160.9% | -187.4% | |
| – | 3.3% | 7.3% | 3.6% | 5.1% | 6.1% | 5.9% | 0.0% | 0.0% | – | 0.0% | 0.0% | |
| – | 619.1% | 385.9% | 258.5% | 408.8% | 395.8% | 597.0% | 9.5% | 12.7% | – | 181.7% | 27.6% | |
| – | 1,012.4% | 517.2% | 269.5% | 409.5% | 395.8% | 622.7% | 9.3% | 11.0% | – | – | – | |
| – | 2,322.2% | 239.0% | 364.0% | -19.9% | -15.9% | -523.0% | -6.9% | 1.3% | – | 56.0% | -46.0% | |
| – | 7.8% | 21.4% | 4.0% | 12.3% | 8.5% | 8.5% | 0.1% | 0.2% | – | 0.0% | 0.1% | |
| – | -9,835.6% | -1,506.6% | -807.7% | 3,388.1% | 842.5% | -9,395.5% | -29.3% | -147.1% | – | -928.1% | 168.3% | |
| – | – | 213.0% | – | – | – | – | – | – | – | – | – | |
| – | 13,957.6% | 4,443.1% | 1,283.1% | 1,036.3% | 1,883.3% | 18,766.8% | 17.8% | – | – | – | – | |
| – | -1,435.4% | – | 936.0% | 1,300.6% | 1,300.6% | 1,300.6% | -15.0% | -16.6% | – | 0.0% | – | |
| – | 12,323.3% | 4,442.8% | 3,592.1% | 1,036.8% | 1,883.3% | 20,067.5% | 84.8% | 136.1% | – | 1,492.3% | 7.9% | |
| – | 2,100.5% | 54.5% | 537.2% | -92.6% | -610.5% | 5,974.6% | 76.4% | -116.6% | – | -596.8% | -11.2% | |
| – | -395.1% | -2,903.1% | -2,251.2% | -4,529.9% | -3,336.3% | -4,697.4% | 20.8% | -105.8% | – | -1,160.9% | -187.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.